Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

11.08
+0.15001.37%
Volume:3.96M
Turnover:43.57M
Market Cap:989.68M
PE:-5.27
High:11.09
Open:10.96
Low:10.91
Close:10.93
Loading ...

Eli Lilly: CVR Holders Would Be Entitled to GET Contingent Payment Upon First Patient Being Dosed With Verve-102 for Ascvd in U.S. Phase 3 Trial

THOMSON REUTERS
·
17 Jun

Eli Lilly - Transaction Is Not Subject to Any Financing Condition

THOMSON REUTERS
·
17 Jun

Eli Lilly - Proposed Deal for Purchase Price of $10.50 per Share in Cash

THOMSON REUTERS
·
17 Jun

U.S. Stocks to Watch: AMD, Nvidia, Sunrun, Regencell, Verve Therapeutics, SRM, Houston American, and More

Dow Jones
·
17 Jun

Verve Therapeutics Soars 82% Following Report of $1.3B Eli Lilly Takeover Talks

Tiger Newspress
·
17 Jun

Stock Track | Verve Therapeutics Skyrockets 80.70% Pre-market on Potential $1.3 Billion Eli Lilly Acquisition

Stock Track
·
17 Jun

Verve Therapeutics Shares Jump 69.7% to $10.6 Premarket After FT Reports Eli Lilly Nears $1.3 Bln Deal for Co

THOMSON REUTERS
·
17 Jun

Verve Therapeutics Stock Soars 75% as Eli Lilly Nears $1.3 Billion Deal for the Gene-Editing Biotech

Reuters
·
17 Jun

BRIEF-Eli Lilly Close To Buying Gene-Editing Biotech Verve Therapeutics - FT

Reuters
·
17 Jun

Verve Therapeutics Holds Annual Stockholders Meeting

TIPRANKS
·
11 Jun

Verve Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
11 Jun

BRIEF-Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

Reuters
·
03 Jun

Verve Therapeutics Announces New Equity Awards for Employees Under 2024 Inducement Stock Incentive Plan

Reuters
·
03 Jun

Verve Therapeutics (VERV) Gets a Buy from H.C. Wainwright

TIPRANKS
·
19 May

Analysts’ Top Healthcare Picks: ADC Therapeutics (ADCT), Verve Therapeutics (VERV)

TIPRANKS
·
15 May

William Blair Remains a Buy on Verve Therapeutics (VERV)

TIPRANKS
·
15 May

Verve Therapeutics Q1 EPS $(0.35) Versus $(0.59) YoY, Sales $32.98M

Benzinga
·
14 May

BRIEF-Verve Therapeutics Q1 Collaboration Revenue USD 32.976 Million

Reuters
·
14 May

Verve Therapeutics Reports Q1 2025 Collaboration Revenue Surge to $33M, Driven by Vertex Collaboration Termination Recognition

Reuters
·
14 May

Verve Therapeutics Q1 Collaboration Revenue USD 32.976 Million

THOMSON REUTERS
·
14 May